12:00 AM
 | 
Oct 04, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Remune: Phase III

Researchers presented data from a 33-patient study comparing highly active antiviral therapy (HAART) in combination with placebo, Chiron Corp.'s Proleukin interleukin-2 (IL-2)...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >